Cytiva, now including Precision NanoSystems, is a global leader in technologies, solutions and services for the development of non-viral delivery of genomic medicines, including mRNA vaccines and therapeutics.
The proprietary NxGen microfluidic mixer enables the reproducible scale-up of mRNA lipid nanoparticles by preserving the critical conditions at the point of formulation.